Bharat Biotech COVAXIN

‘Impossible to Fully Vaccinate All Adults in 2021, Govt Mistakes to Blame’

Many States Say COVID Vaccine Expansion Unlikely Before Third Week of May

Bharat Biotech To See if Third Covaxin Dose Can Provide Protection for Longer

Brazil’s Health Regulator Anvisa Says Covaxin Doesn’t Meet Manufacturing Standards

Bharat Biotech’s Study Says Covaxin Is Likely Effective Against UK Variant

Govt Doctors Association in Karnataka Demands Choice Between Vaccines

Vaccines Safe, Only 0.18% Adverse Events: Govt